Dergiler / Journal of Clinical Research in Pediatric Endocrinology / 2022 / Cilt: 14 - Sayı: 1

Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty

Sayfa
17–28
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

FATs in childhood may have a better prognosis than in adult males.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Estrogen-secreting adrenocortical tumors (ACTs) are quite rare with feminizing adrenocortical tumors (FATs) accounting for 0.37-2% of all ACTs.
📊
Temel Bulgular & Veri:Literature review within Pubmed revealed 34 pediatric patients (22 boys) with FAT among 192 articles.
💡
Sonuç & Katkı:FATs in childhood may have a better prognosis than in adult males.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Estrogen-secreting adrenocortical tumors (ACTs) are quite rare with feminizing adrenocortical tumors (FATs) accounting for 0.37-2% of all ACTs. The aim was to evaluate clinical and hormonal characteristics of FATS as well as treatment options and follow-up in the pediatric age group. Methods: Medical records of children with ACTs presenting to a single center in the last two decades were reviewed. Literature review within Pubmed revealed 34 pediatric patients (22 boys) with FAT among 192 articles. Results: Among the 25 children presenting with ACTs in the last two decades, two new pediatric cases of FAT were identified, one benign and the other malignant, in two genders with different clinical presentations. Literature review showed that FATs are extremely rare tumors that are most commonly seen in men and boys presenting with gynecomastia. FATs are more common in children ≤8 years of age, with a median age at diagnosis of six years. While boys present with contrasexual pseudopuberty signs, girls present with isosexual pseudopuberty. A high estrogen level strongly supports diagnosis, while elevations in other adrenal hormones may be seen. FATs are usually malignant in adults and prognosis is generally very poor. However, in children approximately half are benign although assessment of malignant potential depends on clinical behavior of the tumor. FATs are very unpredictable so even after surgery long-term follow-up is required. FATs presenting in childhood may have a better prognosis than adult presentation tumors as most FATs in children are followed without recurrence of tumor. Conclusion: FATs are more common in children ≤8 years of age, with a median age at diagnosis of six years. FATs in childhood may have a better prognosis than in adult males.

🔖

Bu Makaleye Atıf Yap

VURALLI, D., GÖNÇ, N., OZON, A., EKİNCİ, S., DOĞAN, H. S., TEKGÜL, S., ALİKAŞİFOĞLU, A. (2022). Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 14 - Sayı: 1, 17–28. https://ajindex.com/articles/407292

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Chudler RM, Kay R. Adrenocortical carcinoma in children. Urol Clin North Am 1989;16:469-479
  2. Lalli E, Figueiredo BC. Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors. Front Endocrinol (Lausanne) 2015;6:23
  3. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, Marques R, Pianovski MA, Lacerda L, Cristofani LM, Jenkins J, Rodriguez-Galindo C, Ribeiro RC. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004;22:838-845
  4. Gönç EN, Özön ZA, Cakır MD, Alikaşifoğlu A, Kandemir N. Need for comprehensive hormonal workup in the management of adrenocortical tumors in children. J Clin Res Pediatr Endocrinol 2014;6:68-73
  5. Sutter JA, Grimberg A. Adrenocortical tumors and hyperplasias in childhood-etiology, genetics, clinical presentation and therapy. Pediatr Endocrinol Rev 2006;4:32-39
  6. Ciftci AO, Senocak ME, Tanyel FC, Büyükpamukçu N. Adrenocortical tumors in children. J Pediatr Surg 2001;36:549-554
  7. Moreno S, Guillermo M, Decoulx M, Dewailly D, Bresson R, Proye Ch. Feminizing adreno-cortical carcinomas in male adults. A dire prognosis. Three cases in a series of 801 adrenalectomies and review of the literature. Ann Endocrinol (Paris) 2006;67:32-38
  8. Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol 2011;29:127- 130. Epub 2010 Nov 29 9. Andía Melero VM, García Centeno R, Fernández JB, Vigovich C, Sánchez García-Cervigón P, Jara Albarrán A. Feminizing adrenal tumours in Spain: report of a case and review of the five previously published patients. Endocrinol Nutr 2009;56:470-474
  9. Bhettay E, Bonnici F. Pure oestrogen-secreting feminizing adrenocortical adenoma. Arch Dis Child 1977;52:241-243
  10. Zayed A, Stock JL, Liepman MK, Wollin M, Longcope C. Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma. J Endocrinol Invest 1994;17:275-278
  11. Ardicli B, User IR, Ciftci AO, Akyuz C, Kutluk MT, Yalcin B, Gonc N, Ozon ZA, Alikasifoglu A, Oguz B, Haliloglu M, Orhan D, Tanyel FC, Karnak I, Ekinci S. Adrenocortical tumours in children: a review of surgical management at a tertiary care centre. ANZ J Surg 2021;91:992- 999. Epub 2021 Jan 12 13. Chortis V, Taylor AE, Schneider P, Tomlinson JW, Hughes